The following stories appear in full on today's Vidyya Medical News Service Web site.
Serono, Inc., in cooperation with the US Food and Drug Administration (FDA), is informing patients, physicians and distributing pharmacies about a counterfeit version of Serono’s Serostim 6mg [somatropin (rDNA origin) for injection]. Serostim® is approved for the treatment of AIDS wasting.
For more information: Warning: Counterfeit Version Of Popular AIDS Wasting Drug Appearing In Pharmacies
A new therapy effectively treats a disease similar to multiple sclerosis (MS) in monkeys, and the approach could soon be tested against MS and other autoimmune diseases in humans. The therapy's promising results, reported by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), will be published in the February 1 issue of the Journal of Immunology.
For more information: Experimental Therapy May Lead To Better Multiple Sclerosis Treatment
Randomized controlled trials (RCTs)the gold standard for evaluating medicationsappear to largely under-report or even neglect to report problems involving drug safety, according to researchers supported by the US Agency for Healthcare Research and Quality (AHRQ).
For more information: Researchers Under-Report Drug Safety Problems
A new set of UK guidelines focus on providing evidence-based recommendations for preventing hospital-acquired infections associated with the use of short-to-medium term indwelling urethral catheters in acute care settings. These recommendations are not detailed procedural protocols and need to be incorporated into local guidelines. The recommendations are divided into four distinct interventions: 1. Assessing the need for catheterisation;
2. Selection of catheter type; 3. Aseptic catheter insertion; 4. Catheter maintenance.
For more information: New Guidelines For Preventing Infections Associated With The Insertion And Maintenance Of Short-Term Indwelling Urethral Catheters In Acute Care
Bloodstream infections associated with the insertion and maintenance of central venous catheters (CVC) are among the most dangerous complications that can occur, worsening the severity of the patients’ underlying ill health, prolonging the period of hospitalisation and increasing the cost of care. Every year, almost 6,000 patients in the UK acquire a catheter-related bloodstream infection. Read newly released guidelines from the UK "Epic" guideline project on the subject.
For more information: Guidelines For Preventing Infections Associated With The Insertion And Maintenance Of Central Venous Catheters
Today's Vidyya articles are:
As always, we hope you enjoy the issue.